Evidence map›Paper›PMID 22152031›Full record

ReviewCritical care (London, England)2011

Year in review 2010: Critical Care--Infection.

Leonardo Pagani, Arash Afshari, Stephan Harbarth

Abstract readReview
In one paragraph

Review in Critical care (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Observational
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Molecular Characterization and Antibiogram ofHealthcare (Basel, Switzerland) · 2022
    Article
  7. Observational
  8. Article
  9. Emergence of antibiotic resistanceGenes & diseases · 2019
    Review
  10. Frontiers in pharmacology · 2019
    Article
  11. Observational
  12. Article
  13. Ventilator-associated pneumonia in the ICU.Critical care (London, England) · 2014
    Review
  14. Transparency of reporting in molecular diagnostics.International journal of molecular sciences · 2013
    Article
  15. Ventilators in ICU: A boon or burden.Annals of Indian Academy of Neurology
    Article
  16. Multidrug-resistantTherapeutic advances in infectious disease
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leonardo PaganiAntimicrobial Management Program, Bolzano Central Hospital, Bolzano, Italy.
Arash Afshari
Stephan Harbarth

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections remain among the most important concerns in critically ill patients. Early and reliable diagnosis of infection still poses difficulties in this setting but also represents a crucial step toward appropriate antimicrobial therapy. Increasing antimicrobial resistance challenges established approaches to the optimal management of infections in the intensive care unit. Rapid infection diagnosis, antibiotic dosing and optimization through pharmacologic indices, progress in the implementation of effective antimicrobial stewardship and infection control programs, and management of fungal infections are some of the most relevant issues in this special patient population. During the last 18 months, Critical Care and other journals have provided a wide array of descriptive and interventional clinical studies and scientific reports helping clinical investigators and critical care physicians to improve diagnosis, management, and therapy of infections in critically ill patients.

Indexed as

Critical CareCritical IllnessHumansInfections

Identifiers

PMID22152031
PMCPMC3388701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.